ProQR Therapeutics Reports Q3 Loss, Misses Analyst Expectations
Update: 2025-11-06
Description
ProQR Therapeutics, a Dutch pharmaceutical company, reported a net loss of $12.9 million for Q3, translating to a loss of $0.12 per share, falling short of analysts expectations of $0.10 per share. The company generated $3.4 million in revenue during the period. Despite the underperformance, ProQR continues its operations, with investors and market watchers eagerly anticipating future reports to understand the companys strategies moving forward.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
